LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $16,572,000 | -48.7% | 118,310 | -37.4% | 0.01% | -40.0% |
Q3 2018 | $32,274,000 | +80.8% | 188,926 | +83.6% | 0.01% | +66.7% |
Q2 2018 | $17,855,000 | +92.4% | 102,921 | +28.0% | 0.01% | +100.0% |
Q1 2018 | $9,278,000 | -34.2% | 80,414 | -52.0% | 0.00% | -40.0% |
Q4 2017 | $14,102,000 | +166.6% | 167,513 | +191.7% | 0.01% | +150.0% |
Q3 2017 | $5,290,000 | +124.2% | 57,430 | +95.2% | 0.00% | +100.0% |
Q2 2017 | $2,359,000 | +159.8% | 29,422 | +4.1% | 0.00% | – |
Q4 2016 | $908,000 | +4.7% | 28,269 | -14.6% | 0.00% | – |
Q3 2016 | $867,000 | -43.0% | 33,119 | -40.4% | 0.00% | -100.0% |
Q1 2016 | $1,520,000 | -36.5% | 55,593 | -33.9% | 0.00% | 0.0% |
Q4 2015 | $2,394,000 | +69.4% | 84,143 | +4.1% | 0.00% | 0.0% |
Q3 2015 | $1,413,000 | +28160.0% | 80,845 | +28876.7% | 0.00% | – |
Q2 2015 | $5,000 | – | 279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |